News & Updates

Acid suppressants such as potassium-competitive acid blockers (P-CABs) and proton pump inhibitors (PPIs), when used concomitantly with clopidogrel, carry an increased risk of ischaemic events in stroke patients, according to a retrospective cohort study.

Recent research indicates that depression does not contribute to increased mortality in patients with cardiovascular disease (CVD), and that the observed association is largely attributable to coexisting risk factors and comorbidities.

An alternate-day fasting (ADF) regimen for 3 weeks results in lower blood pressure and myocardial oxygen consumption (MVO2) and improves myocardial blood flow and flow reserve (MFR), reports a recent study.

Treatment with sivelestat in patients undergoing cardiovascular procedures appears to lower the incidence of acute respiratory distress syndrome (ARDS) and all-cause mortality, as reported in a study.

The use of a smartwatch-based atrial fibrillation (AF) screening results in improved detection rates of new-onset AF relative to standard care in patients at increased risk of stroke, reports a study.

Supplementation with niacinamide appears protective against some cardiovascular events, such as myocardial infarction and cardiac arrest, suggests a study.

Quality of care for heart failure (HF) patients varies, with substantial gaps among Asians compared with non-Hispanic Whites, reports a US study.

In patients with uncontrolled hypertension and cardiometabolic comorbidities, renal denervation appears to improve hepatic steatosis, according to a small study.

Peak oxygen consumption (pVO2) in patients with nonobstructive hypertrophic cardiomyopathy (HCM) is reduced following treatment with the beta-blocker bisoprolol but remains unchanged with the calcium-channel blocker verapamil, reports a study.